Sh Fosun Pharma | 600196 - Ebitda

Stock Price
24.13
Daily Change
-0.37 -1.51%
Monthly
-9.63%
Yearly
0.46%
Q2 Forecast
23.64

Sh Fosun Pharma reported CNY1.57B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 5.64B 3.31B Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026